There is also emerging evidence that p53 has a role in the regulation of PDL1 (programmed death ligand 1), a transmembrane protein expressed by tumour cells that is the target of intense scientific interest in relation to its role in disarming anti-tumour immune responses in a range of malignancies [91]. The gene discussed is CD274; the disease is neoplasm.